Additional results from two other human BTSCs (NCH644, NCH421K) demonstrates a similar effect as shown in Figure  8 Table S2 . Genes are differentially expressed after deletion Tlx in brain tumors (Related to Figure 5 ).
Supplemental Experimental Procedures Animal experiment
To induce brain tumors in mice carrying the Nestin--Tv--a transgene, the RCAS--PDGFB/AKT vectors were used for induction of the brain tumors in Ntv--a mice (Holland et al., 2000; Holland et al., 1998) . The DF--1 cells (American Type Culture Collection (ATCC)), an immortalized chicken cell line, were transfected with RCAS vectors.
Then the DF--1 cells infected with the RCAS vectors and producing RCAS retroviruses were collected and 50,000 cells/mouse were injected into the left SVZ of newborn mice. Mice were closely monitored and sacrificed when neurological symptoms were observed. The Kaplan--Meier survival curve was generated with Spss 13.0. For transplantation experiment, Different number of mouse brain tumor cells from primary mouse tumors or from in vitro culture were isolated via FACS using FACSDiva 6.1.3 sorter, the cells were stereotactically implanted into the right brain hemisphere (4 mm lateral and 2 mm ventral from the bregma) of CD1 nu/nu mice (Charles River Laboratories, Sulzfeld, Germany) at a depth of 3 mm. MRI was performed using a 9.4 Tesla experimental MR scanner (Bruker Biospec 94/20 USR) using a 4--channel surface coil as receive RF coil. A T2 relaxometry sequence (repetition time = 5000ms, 6 echoes with echo times ranging from 9.2 to 138ms, in--plane resolution: 0.12mm, 20 slices with slice thickness = 0.5mm) was performed after intraperitoneal injection of 0.05 ml of a gadolinium--based contrast agent.
Microarray and in vitro experiment
RNA concentrations were determined using the NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE). Biotin--labeled cRNA samples for hybridization on Illumina Mouse Sentrix--6 BeadChip arrays (Illumina, Inc.) were prepared according to Illumina's recommended sample labeling procedure based on the modified Eberwine protocol (Eberwine et al., 1992) . In brief, 500ng total RNA was used for complementary DNA (cDNA) synthesis, followed by an amplification/labeling step (in vitro transcription) to synthesize biotin--labeled cRNA according to the Illumina® Total Prep™ RNA Amplification Kit (Life Technologies). Biotin--16--UTP was purchased from Roche Applied Science, Penzberg, Germany. The cRNA was column purified according to TotalPrep RNA Amplification Kit, and eluted in 60--80 µl of water. Quality of cRNA was controlled using the RNA Nano Chip Assay on an Agilent 2100 Bioanalyzer and spectrophotometrically quantified (NanoDrop). Hybridization is performed at 58°C, in GEX--HCB buffer (Illumina Inc.) at a concentration of 100 ng cRNA/µl, unsealed in a wet chamber for 20h. Spike--in controls for low, medium and highly abundant RNAs were added, as well as mismatch control and biotinylation control oligonucleotides. Microarrays were washed once in High Temp Wash buffer (Illumina Inc.) at 55°C and then twice in E1BC buffer (Illumina Inc.) at room temperature for 5 minutes (in between washed with ethanol at room temperature). After blocking for 5 min in 4 ml of 1% (wt/vol) Blocker Casein in phosphate buffered saline Hammarsten grade (Pierce Biotechnology, Inc., Rockford, IL), array signals are developed by a 10--min incubation in 2 ml of 1 µg/ml Cy3--streptavidin (Amersham Biosciences, Buckinghamshire, UK) solution and 1% blocking solution. After a final wash in E1BC, the arrays are dried and scanned. Microarray scanning was done using an iScan array scanner. Data extraction was done for all beads individually, and outliers are removed when > 2.5 MAD (median absolute deviation). All remaining data points are used for the calculation of the mean average signal for a given probe, and standard deviation for each probe was calculated. To knock down Tlx with a shRNA mediated approach, engineered retroviruses were used to coexpress shRNA and a fluorescent marker in human GB cells and their progeny as previously described (Ge et al., 2006) . The following short hairpin sequences were cloned into pUEG retroviral vectors: shRNA--Firefly luciferase: GTGCGTTGCTAGTACCAAC (Dharmacon siDESIGN® Center), shRNA--1: CCGTTCCTACACATAGTGGTT (Sigma TRCN0000021671); shRNA--2: GCTAACACTCTACTGGCTGTA (Sigma TRCN0000021673); High titers of engineered retroviruses (1 x 10 8 unit/ml) were produced by cotransfection of retroviral vectors and vesicular stomatitis viral envelope (VSVG) into 293--GP2 cells (Clontech) followed by ultracentrifugation of viral supernatant. To analyze the proliferation capacity after knock--down of Nr2e1 in vitro, human GB stem cells (T269, NCH644, NCH421K) (Campos et al., 2010; Lemke et al., 2012) were cultured as neurospheres or monolayer. Cultures were infected by the engineered retroviruses expressing ShRNA against luciferase or Nr2e1 1 day after seeding. 2days later, the cells were sorted by a FACSDiva 6.1.3 sorter, and directly plated into 12--well plates. 3 days later, the spheres forming capacity were measured. To analyze the proliferation, 10µm BrdU were added into the monolayer culture for 3 hours, after that the cells were fixed by 4% PFA for 30mins and stained by anti--BrdU and --GFP antibodies.
Antibodies used in this study
The dilutions of primary antibodies used in this study were as follows: GFAP (chicken, 1:1000, Chemicon); Doublecortin (goat, 1:200, SantaCruz); BrdU (mouse, 1:200, Dako); Ki67 (rabbit, 1:500, ABCAM); Olig2 (rabbit, 1:1000, Chemicon); GFP
